Sign in
4

Changes in Ownership

ClearPoint Neuro, Inc. Filed Acc 0001285550-23-000029

Options or other derivatives

  • GM, Biologics & Drug Delivery acquired 59,258 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STIGALL L. JEREMY · GM, Biologics & Drug Delivery

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-06 Grant or award : show line 1 in the form Stock Option (Right to Buy) +14,814 14,814 D
2023-03-06 Grant or award : show line 2 in the form Restricted Stock Units +44,444 44,444 D
Loading xslF345X03/wf-form4_167831228291190.xml…